Platelet serotonin and magnesium concentrations in suicidal and non-suicidal depressed patients

Magnesium Research

Volumn 26, Issue 1, 2013, Pages 9-17

  Ruljancic, Nedjeljka ^a   Mihanovic, Mate ^b   Cepelak, Ivana ^c   Bakliza, Ana ^a   Curkovic, Katarina Dodig ^b  

^a Zagreb Fakultet za dentalnu medicinu i zdravstvo Osijek Zdravstveno veleu ili te Zagreb   (Croatia)

^b JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Depression; Magnesium; Platelet serotonin; Suicidal behaviour

Indexed keywords

ALBUMIN; MAGNESIUM; SEROTONIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CHEMICAL ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; ICD-10; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; SEMI STRUCTURED INTERVIEW; SUICIDAL BEHAVIOR; THROMBOCYTE;

DEPRESSION; MAGNESIUM; PLATELET SEROTONIN; SUICIDAL BEHAVIOUR;

ADULT; BLOOD PLATELETS; CASE-CONTROL STUDIES; DEPRESSION; FEMALE; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; SEROTONIN; SERUM ALBUMIN; SUICIDE, ATTEMPTED; YOUNG ADULT;

EID: 84878234646     PISSN: 09531424     EISSN: 19524021     Source Type: Journal    
DOI: 10.1684/mrh.2013.0332     Document Type: Article

References (56)

1. Wolf FI, Trapani V. Cell (patho) physiology of magnesium. Clin Sci 2008; 114: 27-35.
2. Hamon M, Bourgoin S, Hery F, Simonet G. Activation of tryptophan hydroxylase by adenosine triphosphatase, magnesium and calcium. Mol Pharmacol 1977; 14: 1-13.
3. Champier J, Claustrat B, Besancon R, Eymin C, Killer C, Jouvet A, Chamba G, Fevre-Montage M. Evidence for tryptophan hydroxylase and hydroxy-indol-o-methyl-transferase mRNA in human blood platelets. Life Sci 1997; 60: 2191-2197.
4. Nelson DL, Herbert A, Enjalbert A, Bockert J, Hamon M. Serotonin sensitive adenylate ciklase and serotonin binding sites in the CNS of the rat. Bioch Pharmacol 1980;29: 2445-2543.
5. Haddad JJ. N-methyl-D-aspartate (NMDA) and the regulation of mitogen-activated protein kinase (MAPK) signalling pathways: a revolving neuro-chemical axis for therapeutic intervention? Prog Neurobiol 2005; 77: 252-282.
6. Murck H. Magnesium and affective disorders. Nutr Neurosci 2002;5:375-389.
7. Politi HG, Preston RR. Is it time to rethink the role of Mg in membrane excitability? NeuroReport 2003; 14: 659-678.
8. Cardoso CC, Lobato KR, Binfare RW, Ferreira PK, Rosa AO, Santos ARS, Rodrigues ALS. Evidence for the involvement of the monoaminergic system in the antidepressant-like effect of magnesium. Prog Neuropsychopharmacol Biol Psychiatry 2009;33: 235-242.
9. Poleszak E. Modulation of antidepressant-like activity of magnesium by serotonergic system. J Neural Transm 2007;114:1129-1134.
10. Poleszak E, Wlaz P, Kedzierska E, Nieoczym D, Wro-bel A, Fidecka S, Pilc A, Nowak G. NMDA/glutamate mechanism of antidepressant-like action of magnesium in forced swim test in mice. Pharmacol Biochem Behav 2007; 88:158-164.
11. Szewczyk B, Poleszak E, Sowa-Kucma ME, Siwek M, Dudek D, Ryszewska-Pokrasniewicz B, Radziwon-Zaleska M, Opoka W, Czekaj J, Pilc A, Nowak G. Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action. Pharmacol Rep 2008; 60:588-599.
12. Sartori SB, Whitle N, Hetzenauer A, Singewald N. Magnesium deficiency induces anxiety and HPA axis dysregulation: Modulation by therapeutic drug treatment. Neuropharmacology 2012; 62: 304-312.
13. Singewald N, Sinner C, Hetzenauer A, Sartori SB, Murck H. Magnesium-deficient diet alters depression- and anxiety-related behavior in mice-influenceofdesipramine and Hypericum perforatum extract. Neuropharmacology 2004;47: 1189-1197.
14. Jacka FN, Overland S, Stewart R, Tell GS, Bjel-landI,MykletunA.Association between magnesium intake and depression and anxiety in community-dwelling adults; the Hordaland health study. Aust NZJ Psychiatry 2009; 43:45-52.
15. Elin RJ, Magnesium: RJ. Thefifth but forgotten electrolyte. Am J Clin Pathol 1994; 102: 616-622.
16. Huijgen HJ, Soesan M, Sanders R, Mairuhu WM, Kesecioglu J, Sanders GT. Magnesium level in critically ill patients: What should we measure? Am J Clin Pathol 2000; 114: 688-695.
17. Ryschon TW, Rosenstein DL, Rubinov DR, Niemela JE, Elin RJ, Balaban RS. Relationship between skeletal muscles intracellular ionized magnesium and measurement of blood magnesium. J Lab Clin Med 1996;127:207-213.
18. Saris NEL, Mervaala E, Karppanen H, Khawaja J, Lewenstam A. Magnesium: An update on physiological, clinical and analytical aspects. Clin Chim Acta 2000; 294: 1-26.
19. Arnaud MJ. Update on the assessment of magnesium status. Br J Nutr 2008; 99(Suppl 3):24-36.
20. Plein H, Berk M. The platelet as a peripheral marker in psychiatric illness. Hum Psychopharma-col 2001; 16: 229-236.
21. Frazer A, Ramsey TA, Swann A, Bowden C, Brunswick D, Garver D, Secunda S. Plasma and erythrocyte electrolytes in affective disorders. J Affect Disord 1983; 5: 103-113.
22. Imada Y, Yoshioka S, Ueda T, Katayama S, Kuno Y, Kawahara R. Relationship between serum magnesium levels and clinical background factors in patients with mood disorders. Psychiatry Clin Neu-rosci 2002; 56(5): 509-514.
23. Linder J, Brismar K, Beck-Friis J, Saaf J, Wet-terber L. Calcium and magnesium concentration in affective disorder: Differences between plasma and serum in relation to symptoms. Acta Psychiatr Scand 1989; 80: 527-537.
24. Widmer J, Bovier P, Karege F, Raffin Y, Hilleret H, Gaillard JM, Tissot G. Evolution of blood magnesium, sodium and potassium in depressed patients followed for three months. Neuropsychobiology 1992; 26: 173-179.
25. Widmer J, Stella N, Raffin Y, Bovier P, Gaillard JM, Hilleret H, Tissot G. Blood magnesium, potassium, calcium and cortisol in drug-free depressed patients. Magnes Res 1993;6:33-41.
26. Widmer J, Henrote JG, Raffin Y, Bovier P, Hilleret H, Gaillard JM. Relationship between erythrocyte magnesium, plasma electrolytes and cortisol and intensity of symptoms in major depressed patients. J Affect Disord 1995; 34(3): 201-209.
27. Kirov G, Tsachev KN. Magnesium in schizophrenia and maniac-depressive disease. Neuropsychobiology 1990; 23: 89-91.
28. Nechifor M. Magnesium in major depression. Magnes Res 2009; 22: 163-166.
29. Rasmussen HH, Mortensen PB, Jensen IW. Depression and magnesium deficiency. Int J Psychiatry Med 1989; 19: 57-63.
30. Zieba A, Kata R, Dudek D, Schlegel-Zawadzka M, Nowak G. Serum trace elements in animal models and human depression: Part 3. Magnesium. Relationship with copper. Hum Psychopharmacol Clin Exp 2000;15: 631-635.
31. Young LT, Robb JC, Levitt AJ, Cooke RG, Joffe RT, Serum Mg RT. Ca/Mg ratio in major depressive disorders. Neuropsychobiology 1996; 34: 26-28.
32. Banki CM, Vojnik M, Papp Z, Balla KZ, Arato M. Cerebrospinal fluid magnesium and calcium relate to amine metabolites, diagnosis, and suicide attempts. Biol Psychiatry 1985; 20(2): 163-171.
33. Banki CM, Arato M, Kilts CD. Aminergic studies and cerebrospinal fluid cations in suicide. Ann NY Acad Sci 1986; 487: 221-230.
34. Franke L, Schewe HJ, Muller B, Campman V, Kitzrow W, Uebelhack R, Berghhofer A, Muller-Oerlinghausen B. Serotonergic platelet variables in unmedicated patients suffering from majordepression and healthy subjects-relationship between 5HT content and 5HT uptake. Life Sci 2000; 67: 301-315.
35. Jakovljevic M, Muck-Seler D, Pivac N, Ljubi-cic D, Bujas M, Dodig G. Seasonal influence on platelet 5-HT levels in patients with recurrent major depression and schizophrenia. Biol Psychiatry 1997; 41: 1028-1034.
36. Muck-Seler D, Pivac N, Sagud M, Jakovljevic M, Mihaljevic-Peles A. The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26: 1235-1241.
37. Maurer-Spurej E, Pittendreigh C, Solomons K. The influence of selective serotonin reuptake inhibitors on human platelet serotonin. Thromb Haemost 2004; 91: 119-128.
38. Muck-Seler D, Pivac N, Mustapic M, Crncevic Z, Jakovljevic M, Sagud M. Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women. Psychiatry Res 2004; 127: 217-226.
39. Pivac N, Muck-Seler D, Sagud M, Jakovljevic M, Mustapic M, Mihaljevic-Peles A. Long term sertraline treatment and peripheral biochemical markers in female depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 759-765.
40. Quintana J. Platelet serotonin and plasma trypto-phan decreases in endogenous depression. Clinical, therapeutic and biological correlations. J Affect Disorder 1992; 24: 66-72.
41. Roggenbach J, Muller-Oerlinghausen B, Franke L, Uebelhack R, Blank S, Ahrens B. Peripheral serotonergic markers in acutely suicidal patients. 1. Comparison of serotonergic platelet measures between suicidal individuals, non-suicidal patients with major depression and healthy subjects. J Neural Transm 2007; 114:479-487.
42. Mann IJ, McBride PA, Anderson GM, Mieczkowski TA. Platelet and whole blood serotonin content in depressed inpatients: correlations with acute and life-time psychopathology. Biol Psychiatry 1992; 32: 243-257.
43. Muck-Seler D, Jakovljevic M, Pivac N. Platelet 5-HT concentration and suicidal behaviour in recurrent major depression. J Affect Disord 1996; 39: 73-80.
44. Alvarez JC, Cremniter D, Lesieur P, Gregoire A, Gilton A, Macquin-Mavier I, Jarreau C, Spreux-Varoquaux O C. Low blood cholesterol and low platelet serotonin levels in violent suicide attempters. Biol Psychiatry 1999; 45: 1066-1069.
45. Spreux-Varoquaux O, Alvarez JC, Berlin I, Batista G, Despierre PG, Gilton A, Cremniter D. Differential abnormalities in plasma 5-HIAA and platelet serotonin concentration in violent suicide attempters relationship with impulsivity and depression. Life Sci 2001; 69: 647-657.
46. Cipriani A, Furukawa TA, Salanti G, Higgins JPT, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 2009; 373: 746-758.
47. th ed. Philadelphia: Lippincott Williams&Wilkins; 2004. p. 1652-1660.
48. Nechifor M. Interaction between magnesium and psychotropic drugs. Magnes Res 2008; 21:97-100.
49. Wong ET, Rude RK, Singer FR, Shaw ST. A high prevalence of hypermagnesaemia and hypomagne-saemia in hospitalized patients. Am J Clin Pathol 1983; 79: 348-352.
50. Kroll M, Elin RJ. Relationships between magnesium and protein concentrationinserum. Clin Chem 1985; 31: 244-246.
51. Ruljancic N, Mihanovic M, Cepelak I. Throm-bocyte serotonin and serum cholesterol concentration in suicidal and non suicidal depressed patients. Prog Neuro-Psychopharmacol. Biol Psychiatry 2011; 35: 1261-1267.
52. Kovacic Z, Henigsberg N, Pivac N, Nedic G, Borovecki A. Platelet serotonin concentration and suicidal behaviour in combat related posttraumatic stress disorder. Prog Neuro-Psychopharmacol. Biol Psychiatry 2008; 32: 544-551.
53. Verkes RJ, Fekkes D, Zwindermann AH, Hengeveld MW, Van der Mast RC, Tuyl JP, Kerkhof JFM, Van Kempen GMJ. Platelet serotonin and (3H) parox-etine binding correlate with recurrence of suicidal behaviour. Psychopharmacology 1997; 132: 89-94.
54. Muller-Oerlinghausen B, Roggenbach J, Franke L. Serotonergic platelet markers of suicidal behaviour - do they really exist? J Affect Disord 2004; 79: 13-24.
55. Kim DH, Park YM. The association between suici-dality and serotoninergic dysfunction in depressed patients. J Affect Disord (2013), Article in Press.
56. Uhl I, Illes F, Grassnickel V, Echterhoff S, Norra C, Juckel G. Loudness dependence of auditory evoked potentials (LDAEP) in clinical monitoring of suicidal patients with major depression: a pilot study. Eur Arch Psychiatry Clin Neurosci 2012; 262: 487-492.